Tech Company Financing Transactions
Novelix Pharmaceuticals Funding Round
On 1/1/2005, Novelix Pharmaceuticals raised $250 thousand in funding from private investors.
Transaction Overview
Company Name
Announced On
1/1/2005
Transaction Type
Venture Equity
Amount
$250,000
Round
Undisclosed
Investors
private investors (Gordon Eberwein)
Proceeds Purpose
Capital will be used to pursue company goals regarding new cancer drugs.
Company Information
Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
8008 Girard Ave. 330
La Jolla, CA 92037
USA
La Jolla, CA 92037
USA
Phone
Website
Email Address
Overview
Novelix is a private California-based biotechnology company committed to developing proprietary first-in-class targeted small molecules for cancer therapy.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chairman
Tim Triche
Chief Executive Officer
Burkhard Jansen
Chief Financial Officer
Jeremy Teraoka
Founder
Jonathan Buckley
Founder
Poul Sorensen
VP - Bus. Development
Diane Goostree
VP - Operations
Richard Southard
Browse more venture capital transactions:
Prev: 12/31/2004: VidaCare venture capital transaction
Next: 1/2/2005: Commil venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to report on tech company VC transactions. VC investment data records reported here come from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs